Pre-order Enquiry
Request Free Sample
Global Gastrointestinal Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13851198 | Publishing Date : 14-Feb-2019 | No. of pages : 115
Request Sample
Request Customization
Check Discounts
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Scope of the Report:
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
The worldwide market for Gastrointestinal is expected to grow at a CAGR of roughly 0.9% over the next five years, will reach 35300 million US$ in 2024, from 33600 million US$ in 2019, according to a new study.
This report focuses on the Gastrointestinal in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market Segment by Applications, can be divided into
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal, with price, sales, revenue and global market share of Gastrointestinal in 2017 and 2018.
Chapter 3, the Gastrointestinal competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Gastrointestinal market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Gastrointestinal sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
The worldwide market for Gastrointestinal is expected to grow at a CAGR of roughly 0.9% over the next five years, will reach 35300 million US$ in 2024, from 33600 million US$ in 2019, according to a new study.
This report focuses on the Gastrointestinal in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market Segment by Applications, can be divided into
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal, with price, sales, revenue and global market share of Gastrointestinal in 2017 and 2018.
Chapter 3, the Gastrointestinal competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Gastrointestinal market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Gastrointestinal sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
